NEW TREATMENTS OF HEPATITIS C VIRUS INFECTION

摘要

A method of using alisporivir to therapeutically alter the pharmacokinetics of a medication whereby alisporivir has an effect that achieves and preserves similar safety and efficacy of said drugs with lower doses, less frequent administration, or both.